E

Exact Sciences Corp
D

EXAS

53.360
USD
-0.51
(-0.95%)
مغلق
حجم التداول
55,503
الربح لكل سهم
-0
العائد الربحي
-
P/E
-10
حجم السوق
10,065,706,231
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
BAX
BAX
-0.450
(-1.45%)
30.660 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
BSX
BSX
0.625
(0.60%)
104.250 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
ILMN
ILMN
0.360
(0.36%)
100.710 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
M
MYGN
-0.03000
(-0.53%)
5.60000 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
T
TNDM
-0.275
(-1.61%)
16.785 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: Exact Sciences Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.